WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Lung Cancer efficacy endpoints v1, Cystic lesion has_value >Simple >Complex, Non-measurable lesions has_subtype Non-target lesion, RANO (Macdonald Criteria) classified into Progression, Objective Response Rate (ORR) measured by Tumor Size, Lung Cancer Efficacy Endpoints include Progression free survival (PFS), Therapeutic Efficacy Endpoint is the intersection of Observation or Assessment, Follow-up evaluation summarized_by Measurable lesions, Follow-up evaluation summarized_by New lesions, SF-36 Questionnaire Eight Domains summarized_by Mental Component Summary (MCS), Anatomical region has_option Other, Progression free survival (PFS) assesses Disease progression, Time To Progression (TTP) measured by Defined Time Points, Non-measurable lesions has_location Anatomical region, Baseline assessment has_pertinent_ information Imaging evaluation method, Non-target lesion can_include Cystic lesion, Time-to-Treatment Failure (TTF) measured by Defined Time Points, Effusion/ascites has_value >Yes >No, Disease progression validated_by Tumor assessment, Objective Response Rate (ORR) measured by Defined Time Points, Repeated concepts/instances throughout the CMAP are denoted by dotted outline